Live feed
Filing
SC 13G
SC 13G0000902664-23-006066·Biodexa Pharmaceuticals Plc
Schedule 13G ownership disclosure
BIODEXA PHARMACEUTICALS PLC
Security class unavailable · CUSIP: 59564R708
Event date: 2023-12-21
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 110,558,000
- Percent of class
- 9.9000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902664-23-006066
- Form type
- SC 13G
- Filer
- Biodexa Pharmaceuticals Plc
- CIK
- CIK 1643918
- Filed
- Dec 28, 2023
- Reporting period
- Dec 21, 2023
- Description
- Schedule 13G beneficial ownership